Division of Urology, University of Pennsylvania, Philadelphia, PA; Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA.
Division of Urology, Fox Chase Cancer Center, Philadelphia, PA.
Urology. 2021 Apr;150:41-46. doi: 10.1016/j.urology.2020.08.006. Epub 2020 Aug 13.
To evaluate multidisciplinary female representation at urologic oncology conferences, we reviewed speakership trends at contemporary Society of Urologic Oncology (SUO) and American Society of Clinical Oncology Genitourinary Symposium (GU-ASCO) annual meetings.
Meeting programs from SUO and GU-ASCO from 2015 to 2019 were analyzed. Biographical information was determined by querying institutional websites and social/professional media platforms. Statistical analyses were performed to assess for differences and relationships between male and female authorship based on gender, specialty, professional, and educational factors.
We identified 1102 speakers at genitourinary oncology conferences. Overall, 222 (20%) were female. There was no significant difference between female speakership rates at SUO and GU-ASCO. The overall proportion of female speakers increased over time, but not when analyzing each individual subspecialty conference separately. Several professional and educational differences were noted between genders. Female speakers were more likely to be medical oncologists (P <.001), have more recent years of graduation (2001 vs 1996, P <.001), hold an additional advanced degree (OR 2.09, P = .005), and speak in sessions where other women served as chair (OR 1.42, P = .044). Conversely, female speakers had lower odds of delivering a plenary or keynote address (OR 0.28, P = .015).
We identified a significantly positive trend towards increased female representation within contemporary genitourinary conferences over time; these trends did not remain significant when analyzing each meeting separately. Several important disparities between men and women speakers were identified. Our data suggests that inclusion of women in planning committees may help reduce gender bias and promote diversity within urologic oncology.
为了评估泌尿科肿瘤学会议中的多学科女性代表情况，我们回顾了当代泌尿肿瘤学会（SUO）和美国临床肿瘤学会泌尿生殖系统研讨会（GU-ASCO）年会的演讲者趋势。
分析了 2015 年至 2019 年 SUO 和 GU-ASCO 的会议计划。通过查询机构网站和专业/社交媒体平台确定传记信息。进行统计分析，以评估根据性别、专业、职业和教育因素，男性和女性作者之间的差异和关系。
我们在泌尿生殖系统肿瘤学会议上确定了 1102 位演讲者。总体而言，女性占 222 人（20%）。SUO 和 GU-ASCO 的女性演讲率没有显着差异。随着时间的推移，女性演讲者的比例总体上有所增加，但分别分析每个专业会议时则不然。两性之间存在一些职业和教育差异。女性演讲者更有可能是肿瘤内科医生（P<.001），毕业年限更新（2001 年与 1996 年相比，P<.001），拥有额外的高级学位（OR 2.09，P=.005），并在其他女性担任主席的会议中发言（OR 1.42，P=.044）。相反，女性演讲者发表全体会议或主题演讲的可能性较低（OR 0.28，P=.015）。
我们发现，随着时间的推移，当代泌尿生殖系统会议中女性代表人数呈明显的积极趋势；但当分别分析每个会议时，这些趋势并不显着。还确定了男女演讲者之间的一些重要差异。我们的数据表明，将女性纳入规划委员会可能有助于减少泌尿科肿瘤学中的性别偏见并促进多样性。
